RecruitingOBSERVATIONAL

Self-questionnaire in Osteoporosis

This study aims to develop a better way to identify rare bone conditions in people who have osteoporosis. We know that family history plays a big part in these conditions, so understanding it can help catch them earlier and offer more personalised care. Researchers have created a new questionnaire that asks about common signs of these rare bone diseases. This study will check how well this questionnaire works by comparing its results to information gathered about a person's family health history over the phone. The goal is to make it easier for doctors to find people who might be at risk of these conditions.

At a glance

Status

Recruiting

Sponsor

CHU de Quebec-Universite Laval

Enrolment target

Start

01 Apr 2026

Estimated completion

31 Dec 2027

Osteoporosis

What is this study about?

Osteoporosis is a condition that makes your bones weak and more likely to break. We know that your family's health history can play a big role in whether you develop certain bone conditions. Doctors are always looking for better ways to understand this and offer the right care to each person.

This study is testing a new questionnaire designed by our research team. This questionnaire asks about signs and symptoms linked to rare bone conditions, like osteogenesis imperfecta or hypophosphatasia. The main goal is to see how accurate this questionnaire is at picking out people who might have these conditions, by comparing its answers to detailed family history information collected separately.

If this questionnaire works well, it could become a helpful tool for doctors. It would allow them to more easily screen adults with osteoporosis for these rarer bone issues. This could lead to earlier diagnosis and more personalised care plans, ultimately helping people get the support they need sooner.

Key takeaways

This study tests a new questionnaire for rare bone conditions.
It aims to improve early detection for people with osteoporosis.
Participation involves a questionnaire and a phone chat about family health.
No new medicines or extra hospital visits are required.
Your medical records will be used for some basic health information.
You can stop participating at any time.

Who may be eligible?

To join this study, you need to be an adult, aged 18 or older. You should be a patient at the rheumatology or endocrinology clinics at CHU de Québec-Université Laval and have been diagnosed with osteoporosis. It's also important that you have access to the internet, as some parts of the study might involve online activities.

You won't be able to take part if you are unable to give your consent, can't answer a questionnaire, or don't know much about your family's health history (for example, if you were adopted and don't have this information).

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you get your care at the rheumatology or endocrinology clinics at CHU de Québec-Université Laval?
Do you have osteoporosis?
Do you have internet access at home?
Do you know your family's health history?
Are you able to answer a questionnaire?

Answer every question to see your result.

What does participation involve?

If you join this study, you'll be asked to provide some basic information like your age, gender, and general health details from your existing medical records at CHU de Québec-Université Laval. This will help us understand more about the people taking part and their osteoporosis.

The main part of your participation will involve two steps, about three months apart. You'll either start by filling out the new questionnaire or by having a phone conversation to discuss your family tree and health history. Three months later, you'll do the other part – if you started with the questionnaire, you'll then do the family tree interview, and vice versa. There are no study visits other than what is done during your regular appointments, and no new medications or treatments are involved in this study.

Potential risks and benefits

There are no major risks involved in taking part in this study, as it only involves answering a questionnaire and discussing your family health history. A potential benefit is helping to improve how rare bone diseases are identified, which could help future patients get earlier and better care. Also, sharing your family history could provide you with a clearer understanding of your own risk factors. Remember, you can choose to stop participating in the study at any time without giving a reason.

Locations (1)

CHU de Quebec-Universite Laval
Verified postcode
Québec, Canada· Recruiting

Common questions

What is osteoporosis?

Osteoporosis is a condition that makes your bones weak and more likely to break easily.

What are 'rare genetic bone diseases'?

These are unusual bone conditions that can run in families, like osteogenesis imperfecta (also known as brittle bone disease).

How long will I be involved in the study?

Your direct participation will involve two activities, spaced about three months apart.

Will I have to take any new medicines?

No, this study does not involve taking any new medications or treatments.

Do I need to visit the hospital more often?

No, your participation will not require extra hospital visits; any data collection will be done either online or by phone, or from your existing medical records during your standard appointments.

How to find out more

Laetitia Michou, MD PhD

laetitia.michou@crchudequebec.ulaval.ca +14185254444 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.